Overview

Treatment Outcome of Vascular Depression

Status:
Completed
Trial end date:
2006-04-01
Target enrollment:
Participant gender:
Summary
This 12-week study will evaluate the effectiveness of sertraline (Zoloft®) for treatment of depression associated with small vascular lesions in the brain (vascular depression).
Details
Lead Sponsor:
University of Pennsylvania
Collaborators:
Duke University
National Institute of Mental Health (NIMH)
Treatments:
Sertraline